SCHEMBL5261192

SCHEMBL5261192

CON(C(=O)C1(O)CCCCC1NC(=O)OC(C)(C)C)c1ccnc2cccnc12

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.33
PDE10A Q9Y233 2/20 0.32
MAP4K4 O95819 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
HTT P42858 1/20 0.31
KDM4D Q6B0I6 1/20 0.31
KDM1A O60341 1/20 0.31
MAOB P27338 1/20 0.31
JAK2 O60674 2/20 0.31
JAK1 P23458 2/20 0.31
BTK Q06187 1/20 0.30
OPRM1 P35372 1/20 0.30
OPRD1 P41143 1/20 0.30
OPRK1 P41145 1/20 0.30
OGFRL1 Q5TC84 1/20 0.30
POLB P06746 1/20 0.30
TNKS O95271 1/20 0.30
TNKS2 Q9H2K2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5264532 0.90 MAPT (0.32) KDM4EPDE10AMAP4K4TDP1KDM4D
SCHEMBL5739690 0.83 NFKB1 (0.33) KDM4EPDE10AMAP4K4TDP1ALDH1A1
SCHEMBL5636825 0.78 JAK1 (0.40) PDE10AMAP4K4ALDH1A1KDM4DKDM1A
SCHEMBL6195942 0.77 KDM1A (0.32) KDM4DKDM1AMAOB
SCHEMBL5260297 0.74 KDM4D (0.33) KDM4EPDE10AMAP4K4TDP1ALDH1A1
SCHEMBL5636179 0.74 KDM4D (0.33) KDM4EPDE10AMAP4K4TDP1ALDH1A1
SCHEMBL5748387 0.74 POLB (0.41) PDE10AMAP4K4ALDH1A1JAK2JAK1
SCHEMBL5749947 0.73 SSTR4 (0.32) OPRM1SSTR4
SCHEMBL3577407 0.73 KDM4D (0.32) KDM4EPDE10ATDP1ALDH1A1HPGD
SCHEMBL5748603 0.72 POLB (0.41) KDM4EPDE10AMAP4K4ALDH1A1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1399443-B1 NITROGEN-CONTAINING BICYCLIC HETEROCYCLES FOR USE AS ANTIBACTERIALS SMITHKLINE BEECHAM PLC (GB) 2007-12-12 EP disclosed
US-20070135422-A1 Nitrogen-containing bicycle heterocycles for use as antibacterials SMITHKLINE BEECHAM P.L.C. 2007-06-14 US disclosed
US-7141564-B2 Nitrogen-containing bicyclic heterocycles for use as antibacterials SMITHKLINE BEECHAM P.L.C. (GB) 2006-11-28 US disclosed
US-20040171620-A1 Nitrogen-containing bicyclic heterocycles for use as antibacterials SMITHKLINE BEECHAM P.L.C. (GB) 2004-09-02 US disclosed
EP-1399443-A1 NITROGEN-CONTAINING BICYCLIC HETEROCYCLES FOR USE AS ANTIBACTERIALS SMITHKLINE BEECHAM PLC (GB) 2004-03-24 EP disclosed
WO-2003087098-A1 NITROGEN-CONTAINING BICYCLIC HETEROCYCLES FOR USE AS ANTIBACTERIALS SMITHKLINE BEECHAM P.L.C. (GB) 2003-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040171620-A1 Nitrogen-containing bicyclic heterocycles for use as antibacterials NRDC, NUCB2, NDC1 KDM4E 3867/4885PDE10A 3473/4885MAP4K4 3423/4885
US-20070135422-A1 Nitrogen-containing bicycle heterocycles for use as antibacterials NRDC, NUCB2, NISCH KDM4E 4047/4885PDE10A 2743/4885MAP4K4 2797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.